2407TiP SunRISe-3: TAR-200 plus cetrelimab (CET) or TAR-200 versus intravesical bacillus Calmette-Guérin (BCG) in patients (pts) with BCG-naive high-risk non-muscle-invasive bladder cancer (HR NMIBC)
Andrea Necchi, James W.F. Catto, Thomas Powles, Félix Guerrero‐Ramos, Giuseppe Simone, Neal D. Shore, Jorge Salinas, Axel S. Merseburger, M. Roumiguié, Hiroshi Kitamura, David Morris, Qiang Wei, Fernando Korkes, M. Hasan, Sheng Jin, John Maffeo, Constance Hammond, Hussein Sweiti, Robert A. Somer, Sam S. Chang
Topics & Concepts
Medicinetar (computing)UrologyBladder cancerBacillus (shape)Internal medicineCancerMicrobiologyComputer scienceBiologyProgramming languageBladder and Urothelial Cancer TreatmentsCancer Research and TreatmentsProstate Cancer Treatment and Research